{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:41:41Z","timestamp":1792442501901,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.clindermatol.2008.09.011","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T04:56:09Z","timestamp":1256964969000},"page":"529-536","source":"Crossref","is-referenced-by-count":60,"title":["Childhood melanoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Melinda","family":"Jen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2008.09.011_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0022-3468(90)90402-U","article-title":"Malignant melanoma in children: its management and prognosis","volume":"25","author":"Rao","year":"1990","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.22692","article-title":"Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken","volume":"121","author":"Karlsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<750::AID-CNCR26>3.0.CO;2-5","article-title":"Childhood melanoma survival","volume":"85","author":"Saenz","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib5","series-title":"SEER Cancer Statistics Review, 1975-2005","author":"Ries","year":"2008"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJM199503093321007","article-title":"Melanoma in children","volume":"332","author":"Ceballos","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib7","first-page":"149","article-title":"The diagnosis and treatment of childhood melanoma","volume":"98","author":"Prosdocimo","year":"2002","journal-title":"W V Med J"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00043426-200009000-00008","article-title":"Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population","volume":"22","author":"Gibbs","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib9","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1200\/JCO.2005.02.899","article-title":"Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database","volume":"23","author":"Strouse","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib10","unstructured":"Hoang M, Eichenfield L. The rising incidence of melanoma in children and adolescents. Dermatol Nurs 2000;12:188-9, 92-3."},{"key":"10.1016\/j.clindermatol.2008.09.011_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/000155598441882","article-title":"Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92","volume":"78","author":"Karlsson","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<34::AID-IJC7>3.0.CO;2-2","article-title":"Childhood cancer incidence in Australia, 1982-1991","volume":"65","author":"McWhirter","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ijc.2910630602","article-title":"Incidence of cutaneous childhood melanoma in Queensland, Australia","volume":"63","author":"Whiteman","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archderm.133.3.295","article-title":"Differences in malignant melanoma between children and adolescents. A 35-year epidemiological study","volume":"133","author":"Berg","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archderm.133.3.363","article-title":"Malignant melanoma in children. A review","volume":"133","author":"Ruiz-Maldonado","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08880010290057327","article-title":"Cutaneous melanoma in childhood and adolescence","volume":"19","author":"Hamre","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib17","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejca.2006.07.001","article-title":"Skin cancer incidence and survival in European children and adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project","volume":"42","author":"de Vries","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1200\/JCO.2006.08.8310","article-title":"Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base","volume":"25","author":"Lange","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00007611-197809000-00009","article-title":"Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and end results","volume":"71","author":"Boddie","year":"1978","journal-title":"South Med J"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0738-081X(01)00227-9","article-title":"Diagnosis and management of nevi and cutaneous melanoma in infants and children","volume":"20","author":"Fishman","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2002.120602","article-title":"Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma","volume":"47","author":"Richardson","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib22","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0959-8049(01)00006-5","article-title":"Childhood melanoma in Europe since 1978: a population-based survival study","volume":"37","author":"Conti","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00006534-197404000-00007","article-title":"The risk of malignancy in large congenital nevi","volume":"53","author":"Kaplan","year":"1974","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib25","doi-asserted-by":"crossref","unstructured":"Marghoob A. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002;20:607-16, viii.","DOI":"10.1016\/S0733-8635(02)00030-X"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1542\/peds.2004-0471","article-title":"Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution","volume":"115","author":"Ferrari","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaad.2005.07.013","article-title":"Malignant melanoma in childhood and adolescence: report of 13 cases","volume":"53","author":"Jafarian","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","article-title":"Melanoma and sun exposure: an overview of published studies","volume":"73","author":"Elwood","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0190-9622(90)70036-H","article-title":"Melanoma in children","volume":"22","author":"Roth","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.suronc.2007.09.006","article-title":"Melanoma in children and adolescents","volume":"16","author":"Downard","year":"2007","journal-title":"Surg Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib31","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.ejca.2003.06.001","article-title":"Melanoma in children and adolescents","volume":"39","author":"Pappo","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1529-8019.2005.05012.x","article-title":"Congenital melanocytic nevi needing treatment","volume":"18","author":"Tromberg","year":"2005","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2004.07.020","article-title":"Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management","volume":"52","author":"Tannous","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07218.x","article-title":"Melanoma risk in congenital melanocytic naevi: a systematic review","volume":"155","author":"Krengel","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib35","doi-asserted-by":"crossref","unstructured":"Schaffer J, Bolognia J. The clinical spectrum of pigmented lesions. Clin Plast Surg 2000;27:391-408, viii.","DOI":"10.1016\/S0094-1298(20)32735-8"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0190-9622(91)70115-I","article-title":"Neurocutaneous melanosis: definition and review of the literature","volume":"24","author":"Kadonaga","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1067\/mjd.2002.120471","article-title":"Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients","volume":"46","author":"Schmid-Wendtner","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0190-9622(95)91284-3","article-title":"Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families","volume":"33","author":"Novakovic","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib39","doi-asserted-by":"crossref","unstructured":"Greene M. Dysplastic nevus syndrome. Hosp Pract (Off Ed) 1984;19:91-103, 7-8.","DOI":"10.1080\/21548331.1984.11702727"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib40","doi-asserted-by":"crossref","unstructured":"Salopek T. The dilemma of the dysplastic nevus. Dermatol Clin 2002;20:617-28, viii.","DOI":"10.1016\/S0733-8635(02)00026-8"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib41","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jnci\/89.19.1460","article-title":"Germline CDKN2A mutations in childhood melanoma","volume":"89","author":"Whiteman","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdermsci.2006.11.016","article-title":"A French CDK4-positive melanoma family with a co-inherited EDNRB mutation","volume":"46","author":"Soufir","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700094","article-title":"Population-based prevalence of CDKN2A mutations in Utah melanoma families","volume":"126","author":"Eliason","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/CMR.0b013e3282f1d328","article-title":"The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy","volume":"17","author":"Gensini","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.20518","article-title":"Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas","volume":"47","author":"Helsing","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2133.2005.06846.x","article-title":"CDKN2A mutations in Scottish families with cutaneous melanoma: results from 32 newly identified families","volume":"153","author":"Lang","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib48","first-page":"461","article-title":"American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma","volume":"41","author":"Ung-Juurlink","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/j.seminoncol.2007.09.006","article-title":"Genetics: what advice for patients who present with a family history of melanoma?","volume":"34","author":"Newton Bishop","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaad.2004.04.045","article-title":"Genetic testing in hereditary melanoma","volume":"51","author":"Tsao","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib51","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1054\/bjoc.2001.1991","article-title":"CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation","volume":"85","author":"Della Torre","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CMR.0b013e328014a2cd","article-title":"CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population","volume":"17","author":"Pjanova","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20202","article-title":"A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation","volume":"44","author":"Molven","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008390-200202000-00008","article-title":"Rarity of CDK4 germline mutations in familial melanoma","volume":"12","author":"Goldstein","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0190-9622(99)70564-5","article-title":"Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic","volume":"40","author":"Snels","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib57","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1523-1747.ep12374280","article-title":"Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society","volume":"102","author":"Garbe","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(87)70230-8","article-title":"Number of melanocytic nevi as a major risk factor for malignant melanoma","volume":"17","author":"Holly","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib59","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/bjc.1996.302","article-title":"Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study","volume":"73","author":"Bataille","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(89)92097-7","article-title":"Personal risk-factor chart for cutaneous melanoma","volume":"2","author":"MacKie","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/1097-0142(19900715)66:2<387::AID-CNCR2820660232>3.0.CO;2-J","article-title":"Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma","volume":"66","author":"Grob","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib62","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/1097-0142(20000615)88:12<2703::AID-CNCR8>3.0.CO;2-Q","article-title":"Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study","volume":"88","author":"Naldi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0091-7435(88)90003-5","article-title":"Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma","volume":"17","author":"Roush","year":"1988","journal-title":"Prev Med"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O","article-title":"Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia","volume":"67","author":"Grulich","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib65","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.277.18.1439","article-title":"Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma","volume":"277","author":"Tucker","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib66","first-page":"155","article-title":"Development of cancer in transplantation patients","volume":"12","author":"Penn","year":"1978","journal-title":"Adv Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-102-1-37","article-title":"Cutaneous malignant melanoma after Hodgkin's disease","volume":"102","author":"Tucker","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib68","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.305.6857.799","article-title":"Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi","volume":"305","author":"Baird","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib69","first-page":"142","article-title":"Malignant melanoma in childhood and adolescence","volume":"52","author":"Melnik","year":"1986","journal-title":"Am Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archderm.138.5.625","article-title":"Reliability of the histopathologic diagnosis of malignant melanoma in childhood","volume":"138","author":"Wechsler","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib71","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jpedsurg.2005.03.014","article-title":"Survival in sentinel lymph node-positive pediatric melanoma","volume":"40","author":"Roaten","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib72","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1245\/s10434-006-9142-5","article-title":"Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features","volume":"13","author":"Gamblin","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00000478-200201000-00005","article-title":"Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors","volume":"26","author":"Lohmann","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cncr.11074","article-title":"Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients","volume":"97","author":"Su","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ssu.2980080611","article-title":"Cutaneous melanoma: prognosis and treatment results worldwide","volume":"8","author":"Balch","year":"1992","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1525-1470.2002.00032.x","article-title":"\u201cSafe\u201d Spitz and its alternatives","volume":"19","author":"LeBoit","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib77","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000372-200408000-00008","article-title":"\u201cAtypical\u201d Spitz's nevus, \u201cmalignant\u201d Spitz's nevus, and \u201cmetastasizing\u201d Spitz's nevus: a critique in historical perspective of three concepts flawed fatally","volume":"26","author":"Mones","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib78","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO;2-L","article-title":"Cutaneous melanoma and atypical Spitz tumors in childhood","volume":"76","author":"Barnhill","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1525-1470.2002.00056.x","article-title":"A current dilemma in histopathology: atypical spitz tumor or Spitzoid melanoma?","volume":"19","author":"Gurbuz","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib81","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<646::AID-IJC2>3.0.CO;2-H","article-title":"Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases","volume":"80","author":"Sander","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib82","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib83","series-title":"NCCN clinical practice guidelines in oncology: melanoma (V.2.2008)","author":"NCCN","year":"2008"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib84","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jpedsurg.2007.05.028","article-title":"Assessment of value of the sentinel lymph node biopsy in melanoma in children and adolescents and applicability of subcutaneous infusion anesthesia","volume":"42","author":"Topar","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jpedsurg.2005.01.045","article-title":"Melanoma in children and the use of sentinel lymph node biopsy","volume":"40","author":"B\u00fctter","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib86","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/1097-0142(19890101)63:1<199::AID-CNCR2820630132>3.0.CO;2-C","article-title":"Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents","volume":"63","author":"Baas","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib87","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/1097-0142(19871015)60:8<1720::AID-CNCR2820600805>3.0.CO;2-H","article-title":"Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma","volume":"60","author":"Boddie","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib88","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.1984.2.11.1229","article-title":"Malignant melanoma in childhood: clinical course and response to chemotherapy","volume":"2","author":"Hayes","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib89","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-4632.2005.02612.x","article-title":"Childhood melanoma: update and treatment","volume":"44","author":"Huynh","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-3955(16)33245-X","article-title":"Immunology and immunotherapy of childhood neoplasia","volume":"23","author":"Bernstein","year":"1976","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib91","first-page":"158","article-title":"Immunological factors which influence response to immunotherapy in malignant melanoma","volume":"68","author":"Morton","year":"1970","journal-title":"Surgery"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00006534-198309000-00019","article-title":"Congenital nevocellular nevus: a review of the treatment controversy and a report of 46 cases","volume":"72","author":"Arons","year":"1983","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib93","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJM197601292940501","article-title":"Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma","volume":"294","author":"Eilber","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","article-title":"Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients","volume":"41","author":"K\u00f6lmel","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib95","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00000421-198410000-00031","article-title":"Survival after malignant melanoma in a black child. A case report and review of the literature","volume":"7","author":"Moritz","year":"1984","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib96","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/cncr.20166","article-title":"Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group","volume":"100","author":"Agarwala","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib97","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdg120","article-title":"Adjuvant therapy of cutaneous melanoma: the interferon debate","volume":"14","author":"Kefford","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib98","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2407-6-44","article-title":"Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]","volume":"6","author":"Chiarion-Sileni","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.20860","article-title":"The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma","volume":"103","author":"Navid","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib101","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000658-199809000-00004","article-title":"Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response","volume":"228","author":"Rosenberg","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib102","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1200\/JCO.2001.19.15.3477","article-title":"Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma","volume":"19","author":"Phan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib103","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/1097-0142(19950615)75:12<2959::AID-CNCR2820751225>3.0.CO;2-R","article-title":"A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study","volume":"75","author":"Bauer","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib104","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1158\/1078-0432.CCR-05-2000","article-title":"A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group","volume":"12","author":"Osenga","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1097-0142(19930715)72:2<623::AID-CNCR2820720248>3.0.CO;2-S","article-title":"Continuous infusion of interleukin-2 in children with refractory malignancies","volume":"72","author":"Ribeiro","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00043426-199211000-00005","article-title":"A phase I study of interleukin-2 in children with cancer","volume":"14","author":"Roper","year":"1992","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib107","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00043426-200208000-00016","article-title":"Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide","volume":"24","author":"Soni","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib108","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ctrv.2007.10.003","article-title":"Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review","volume":"34","author":"Hamm","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib109","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2006.10.1709","article-title":"Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma","volume":"25","author":"Mitchell","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib110","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1200\/JCO.2007.12.0253","article-title":"Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients","volume":"25","author":"Ives","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib111","first-page":"CD005413","article-title":"Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma","author":"Sasse","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CAD.0b013e3282f2c0bc","article-title":"Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma","volume":"19","author":"Recchia","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib113","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdm565","article-title":"Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)","volume":"19","author":"Spieth","year":"2008","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2008.09.011_bib114","doi-asserted-by":"crossref","first-page":"B4","DOI":"10.1016\/j.vaccine.2007.06.033","article-title":"Vaccine therapy for melanoma: current status and future directions","volume":"25","author":"Terando","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.1994.12.2.402","article-title":"Increased effectiveness of interferon alfa-2b following active specific immunotherapy for melanoma","volume":"12","author":"Mitchell","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib116","first-page":"3696","article-title":"Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha","volume":"8","author":"Vaishampayan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2008.09.011_bib117","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cncr.22818","article-title":"Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis","volume":"110","author":"Livestro","year":"2007","journal-title":"Cancer"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X08001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X08001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:46:04Z","timestamp":1634089564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X08001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0738081X08001880"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2008.09.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}